Search research articles
Contact Us
Filters
Showing results (261-270 of 288) with videos related to
Page
of 29
Sort By:
Transplantation and Cellular Therapy
|
April 6, 2021
Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1
M Meaghan Granger, Arlene Naranjo, Rochelle Bagatell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 2011
miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples
Katleen De Preter, Pieter Mestdagh, Joëlle Vermeulen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2017
Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group
Amy K Erbe, Wei Wang, Lakeesha Carmichael, et al.
Nature Genetics
|
May 5, 2009
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
Mario Capasso, Marcella Devoto, Cuiping Hou, et al.
Cell Reports Methods
|
August 9, 2022
Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer
Guinevere G Connelly, Orville O Kirkland, Seven Bohannon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2023
Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease
Mary Eapen, Ruta Brazauskas, David A Williams, et al.
Pediatric Blood & Cancer
|
November 3, 2020
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma
Karen D Wright, Xiaopan Yao, Wendy B London, et al.
The New England Journal of Medicine
|
May 9, 2008
Chromosome 6p22 locus associated with clinically aggressive neuroblastoma
John M Maris, Yael P Mosse, Jonathan P Bradfield, et al.
Blood
|
June 3, 2026
Long-term stability of posttranscriptional genetic silencing of BCL11A using a shmiR vector in Sickle Cell Disease
Erica B Esrick, Leslie Lehmann, Amy Federico, et al.
Nature
|
June 19, 2009
Copy number variation at 1q21.1 associated with neuroblastoma
Sharon J Diskin, Cuiping Hou, Joseph T Glessner, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 288) with videos related to
Sort By:
Page
of 29
Transplantation and Cellular Therapy
|
April 6, 2021
Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1
M Meaghan Granger, Arlene Naranjo, Rochelle Bagatell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 2011
miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples
Katleen De Preter, Pieter Mestdagh, Joëlle Vermeulen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2017
Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group
Amy K Erbe, Wei Wang, Lakeesha Carmichael, et al.
Nature Genetics
|
May 5, 2009
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
Mario Capasso, Marcella Devoto, Cuiping Hou, et al.
Cell Reports Methods
|
August 9, 2022
Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer
Guinevere G Connelly, Orville O Kirkland, Seven Bohannon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2023
Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease
Mary Eapen, Ruta Brazauskas, David A Williams, et al.
Pediatric Blood & Cancer
|
November 3, 2020
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma
Karen D Wright, Xiaopan Yao, Wendy B London, et al.
The New England Journal of Medicine
|
May 9, 2008
Chromosome 6p22 locus associated with clinically aggressive neuroblastoma
John M Maris, Yael P Mosse, Jonathan P Bradfield, et al.
Blood
|
June 3, 2026
Long-term stability of posttranscriptional genetic silencing of BCL11A using a shmiR vector in Sickle Cell Disease
Erica B Esrick, Leslie Lehmann, Amy Federico, et al.
Nature
|
June 19, 2009
Copy number variation at 1q21.1 associated with neuroblastoma
Sharon J Diskin, Cuiping Hou, Joseph T Glessner, et al.
Page
of 29